Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jincheng Pharmaceutical is a leading Chinese pharmaceutical group specializing in the research/development/manufacture of antibiotics—especially cephalosporins—and other therapeutic agents such as peptides/glutathione-based biologics. The company operates across the full pharma value chain from raw materials to finished drugs with significant commercial operations domestically and internationally. Its product portfolio covers anti-infectives/infectious diseases but also gynecology/women's health care products plus chronic/pediatric/hormonal/liver indications. With over eighty marketed or pipeline programs—including several that have passed regulatory consistency evaluations—it stands out among China's most innovative pharma manufacturers with robust GMP-compliant facilities supporting both its own brands/products plus contract development/manufacturing services globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Jincheng Pharmaceutical.